<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ye ZH</submitter><funding>National Natural Science Foundation of China</funding><pagination>8513747</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9071859</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2022</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Neoadjuvant immunotherapy is promising for locally advanced non-small-cell lung cancer (NSCLC). The &lt;i>in situ&lt;/i> immune patterns, as a predictor of PD-1/PD-L1 blockade outcomes, of the primary tumor (PT) and metastatic lymph nodes (mLNs) are unknown.&lt;h4>Methods&lt;/h4>Multiplex immunofluorescence staining and multispectral imaging were used to evaluate the &lt;i>in situ&lt;/i> immune patterns of T cells (CD3+) and cytotoxic T cells (CD8+) in terms of density, location (center of tumor (CT) and invasive margin (IM)), and the PD-L1 expression status of tumor cells and stromal T cells of paired PTs and mLNs in 38 stage III NSCLCs.&lt;h4>Results&lt;/h4>The densities of T cells and cytotoxic T cells were correlated between PTs and mLNs at both CT and IM. Higher densities of stromal T cell</pubmed_abstract><journal>Journal of immunology research</journal><pubmed_title>Different &lt;i>In Situ&lt;/i> Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy.</pubmed_title><pmcid>PMC9071859</pmcid><funding_grant_id>82002407</funding_grant_id><pubmed_authors>Long H</pubmed_authors><pubmed_authors>Ye ZH</pubmed_authors><pubmed_authors>Zhao ZR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Different &lt;i>In Situ&lt;/i> Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy.</name><description>&lt;h4>Background&lt;/h4>Neoadjuvant immunotherapy is promising for locally advanced non-small-cell lung cancer (NSCLC). The &lt;i>in situ&lt;/i> immune patterns, as a predictor of PD-1/PD-L1 blockade outcomes, of the primary tumor (PT) and metastatic lymph nodes (mLNs) are unknown.&lt;h4>Methods&lt;/h4>Multiplex immunofluorescence staining and multispectral imaging were used to evaluate the &lt;i>in situ&lt;/i> immune patterns of T cells (CD3+) and cytotoxic T cells (CD8+) in terms of density, location (center of tumor (CT) and invasive margin (IM)), and the PD-L1 expression status of tumor cells and stromal T cells of paired PTs and mLNs in 38 stage III NSCLCs.&lt;h4>Results&lt;/h4>The densities of T cells and cytotoxic T cells were correlated between PTs and mLNs at both CT and IM. Higher densities of stromal T cell</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-05-31T23:12:08.456Z</modification><creation>2024-11-12T02:28:07.812Z</creation></dates><accession>S-EPMC9071859</accession><cross_references><pubmed>35528615</pubmed><doi>10.1155/2022/8513747</doi></cross_references></HashMap>